Mirum Pharmaceuticals (MIRM) Stock Price, Quote, News & History | Benzinga

Mirum Pharmaceuticals Inc (MIRM) Stock Price, Quote, News & History

MIRMNASDAQ

Trade with Public

Trade with Public

$98.05

0.590.61%

At close: Aug 28, 5:00 PM EST

$98.05

0.590.61%

Pre-Market: 7:29 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$98.05

Volume / Avg.

1.18K / 792.48K

Day Range

- - -

52 Wk Range

63.23 - 130.00

Market Cap

$5.98B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

13.96%

Days to Cover

7.27

Recent Mirum Pharmaceuticals, Inc. News

This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Wall Street analysts changed ratings on top names. Check our analyst ratings page for full updates. THG, BFRI covered.

Avi Kapoor

This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. See what other analysts think of these stocks.

Avi Kapoor

This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts have mixed views on OKLO, XE, MIRM, TILE, and TYRA.

Avi Kapoor

Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets

Mirum stock rises after Phase 2b VISTAS data for volixibat; AZURE-1 results and technical levels highlight momentum and key price zones.

Vandana Singh

Top 3 Health Care Stocks That May Implode In Q1

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-227.27M

Investing Cash Flow (TTM)

-172.78M

Financing Cash Flow (TTM)

506.61M

Free Cash Flow (TTM)

-263.74M

Capital Expenditure (TTM)

-36.47M

Net Change in Cash (TTM)

106.56M

Analyst Trends and Forecast

7

May

2

Jun

2

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.30B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

8.90

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-14.36%

Earnings Yield % (FWD)

-15.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.17

Company Debt

Total Debt

$750.08M

LT Debt

$750.08M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$330.73M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$98.05

Volume / Avg.

1.18K / 792.48K

Day Range

- - -

52 Wk Range

63.23 - 130.00

Market Cap

$5.98B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

13.96%

Days to Cover

7.27

About

Sector

Health Care

Industry

Biotechnology

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestat...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Mirum Pharmaceuticals (MIRM) stock?

A

You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Mirum Pharmaceuticals (MIRM) competitors?

A

Other companies in Mirum Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Mirum Pharmaceuticals (MIRM) stock?

A

Mirum Pharmaceuticals has a consensus price target of $110.35.

Q

What is the current price for Mirum Pharmaceuticals (MIRM)?

A

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $98.05 last updated September 1, 2026 at 5:03 AM EDT.

Q

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

A

There are no upcoming dividends for Mirum Pharmaceuticals.

Q

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

A

Mirum Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Mirum Pharmaceuticals (MIRM) going to split?

A

There is no upcoming split for Mirum Pharmaceuticals.

Q

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

A

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.